Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.
Baumeier C, Schlüter L, Saussenthaler S, Laeger T, Rödiger M, Alaze SA, Fritsche L, Häring HU, Stefan N, Fritsche A, Schwenk RW, Schürmann A.
Baumeier C, et al. Among authors: haring hu.
Mol Metab. 2017 Oct;6(10):1254-1263. doi: 10.1016/j.molmet.2017.07.016. Epub 2017 Aug 4.
Mol Metab. 2017.
PMID: 29031724
Free PMC article.